PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1677303-4	1991	administration of neurotensin, on extracellular striatal DOPAC following amfonelic acid, with the effects of both classical and atypical neuroleptics.	3,4-Dihydroxyphenylacetic Acid	57-62	neurotensin	Homo sapiens	18-29	
1715498-2	1991	The in vitro voltammetric signal recorded in a solution containing 3,4-dihydroxyphenylacetic acid (10(-4) M) was attenuated after the addition of thyrotropin releasing hormone, neuromedin N and neurotensin (10(-5) M).	3,4-Dihydroxyphenylacetic Acid	67-97	neurotensin	Homo sapiens	194-205	
1715498-3	1991	The administration of neurotensin (1 or 3 micrograms/microliters) into the nucleus accumbens adjacent to the carbon fibre electrode produced a decrease in the extracellular 3,4-dihydroxyphenylacetic acid peak.	3,4-Dihydroxyphenylacetic Acid	173-203	neurotensin	Homo sapiens	22-33	
1715498-5	1991	In contrast, neurotensin administered into the ventral tegmental area increased the 3,4-dihydroxyphenylacetic acid peak in the nucleus accumbens as previously reported.	3,4-Dihydroxyphenylacetic Acid	84-114	neurotensin	Homo sapiens	13-24